ArticlePest management science2026
Assessing the potential for insecticide cross-resistance to a novel insecticide in the Colorado potato beetle (Leptinotarsa decemlineata) using phenotypic and transcript expression analysis.
Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCross-resistance in the Colorado potato beetle (Leptinotarsa decemlineata) threatens insecticide efficacy and sustainable pest management. While metabolic detoxification is often implicated in resistance, its role in driving cross-resistance evolution to novel insecticides remains unclear. Here, we evaluated phenotypic and transcriptional responses to both the widely used neonicotinoid imidacloprid and the novel and recently registered insecticide isocycloseram across multiple L. decemlineata populations within the United States. We tested for pre-existing genetic variation and expression patterns linked to detoxification pathways.
resultsSeveral populations showed significant phenotypic resistance to imidacloprid, while all populations remained more susceptible to isocycloseram. However, positive correlations between the responses to imidacloprid and isocycloseram provide evidence for emerging phenotypic cross-resistance. Transcript expression analysis revealed significant, but inconsistently patterned treatment group-, population-, and dose-based responses. Inducible up-regulation of transcript expression was observed only in the imidacloprid treated samples.
conclusionThese findings support the presence of phenotypic cross-resistance in L. decemlineata, however, transcriptomic analyses of a subset of metabolic detoxification genes did not reveal consistent expression patterns across populations, treatments, or doses, limiting definitive inference about the contribution of detoxification pathways to this response. Variation seen here in gene expression across populations underscores the complexity of resistance evolution and the need for further investigation into the mechanisms underlying cross-resistance. © 2026 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.